These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 21885264)

  • 21. Congenital toxoplasmosis: therapeutic strategies.
    Foulon W
    Arch Pediatr; 2003 Feb; 10 Suppl 1():10-1. PubMed ID: 12802954
    [No Abstract]   [Full Text] [Related]  

  • 22. [Congenital toxoplasmosis following infection occurring late in pregnancy].
    Ben Abdallah R; Siala E; Maatoug R; Souissi O; Aoun K; Bouratbine A
    Arch Pediatr; 2011 Jul; 18(7):758-60. PubMed ID: 21632221
    [TBL] [Abstract][Full Text] [Related]  

  • 23. First case of congenital toxoplasmosis from Nepal.
    Rai SK; Sharma A; Shrestha RK; Pradhan P
    Nepal Med Coll J; 2011 Mar; 13(1):64-6. PubMed ID: 21991707
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Sulfadiazine Hypersensitivity and Desensitization in Children With Congenital Toxoplasmosis: A Report on Two Cases.
    Yamamoto K; Kutsuna S; Kato Y; Goishi K; Shichino H; Ohmagari N;
    Pediatr Infect Dis J; 2021 Apr; 40(4):324-326. PubMed ID: 33181786
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Treatment of toxoplasmosis in the pregnant mother and newborn child.
    Stray-Pedersen B
    Scand J Infect Dis Suppl; 1992; 84():23-31. PubMed ID: 1290070
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Delayed onset of severe neonatal toxoplasmosis.
    Al-Hamod D; Vauloup C; Goulet M; Zupan-Simunek V; Castel C; Boileau P
    J Perinatol; 2010 Mar; 30(3):231-2. PubMed ID: 20182429
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Limitations of prenatal treatment of congenital toxoplasmosis with a sulfadiazine-pyrimethamine combination].
    Boulot P; Pratlong F; Sarda P; Deschamps F; Hedon B; Laffargue F; Viala JL
    Presse Med; 1990 Mar; 19(12):570. PubMed ID: 2139220
    [No Abstract]   [Full Text] [Related]  

  • 28. [Diagnosis and treatment of congenital toxoplasmosis].
    Koskiniemi M
    Duodecim; 1993; 109(14):1260-4. PubMed ID: 8062703
    [No Abstract]   [Full Text] [Related]  

  • 29. [Congenital toxoplasmosis in the Alpes-Maritimes region. Apropos of 26 cases observed between 1984 and 1990].
    Ferret N; Marty P; Tordjman C; Deville A; Tommasi C; Velin P; Mariani R; Le Fichoux Y
    Pediatrie; 1992; 47(6):467-71. PubMed ID: 1331966
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Sulfadiazine, pyrimethamine, spiramycin and folic acid in congenital toxoplasmosis].
    Sedan J
    Mars Med; 1967; 104(4):343-5. PubMed ID: 5621539
    [No Abstract]   [Full Text] [Related]  

  • 31. [Toxoplasmosis].
    Maeda T
    Nihon Rinsho; 2003 Feb; 61 Suppl 2():603-7. PubMed ID: 12722288
    [No Abstract]   [Full Text] [Related]  

  • 32. [Significance of post-partum diagnosis of congenital toxoplasmosis primary maternal infection at the end of the pregnancy].
    Wirden M; Botterel F; Romand S; Ithier G; Bourée P
    J Gynecol Obstet Biol Reprod (Paris); 1999 Oct; 28(6):566-7. PubMed ID: 10598352
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Radiology casebook. Congenital toxoplasmosis: a case report.
    Pan J; Carey BE
    J Perinatol; 1998; 18(6 Pt 1):489-91. PubMed ID: 9848769
    [No Abstract]   [Full Text] [Related]  

  • 34. [Letter: Significance of Toxoplasma infections for public health].
    Koppe JG
    Ned Tijdschr Geneeskd; 1975 Sep; 119(38):1477. PubMed ID: 1165816
    [No Abstract]   [Full Text] [Related]  

  • 35. Central nervous system toxoplasmosis in adult Ethiopians.
    Amogne W; Teshager G; Zenebe G
    Ethiop Med J; 2006 Apr; 44(2):113-20. PubMed ID: 17447372
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Severe sulfadiazine hypersensitivity in a child with reactivated congenital toxoplasmic chorioretinitis.
    McLeod R; Khan AR; Noble GA; Latkany P; Jalbrzikowski J; Boyer K;
    Pediatr Infect Dis J; 2006 Mar; 25(3):270-2. PubMed ID: 16511396
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Hyperpigmentation due to pyrimethamine use.
    Ozturk R; Engin A; Ozaras R; Mert A; Tabak F; Aktuğlu Y
    J Dermatol; 2002 Jul; 29(7):443-5. PubMed ID: 12184645
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Randomized controlled trial of pyrimethamine plus sulfadiazine versus trimethoprim plus sulfamethoxazole for treatment of toxoplasmic encephalitis in AIDS patients.
    Kongsaengdao S; Samintarapanya K; Oranratnachai K; Prapakarn W; Apichartpiyakul C
    J Int Assoc Physicians AIDS Care (Chic); 2008; 7(1):11-6. PubMed ID: 17517949
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Levels of pyrimethamine in sera and cerebrospinal and ventricular fluids from infants treated for congenital toxoplasmosis. Toxoplasmosis Study Group.
    McLeod R; Mack D; Foss R; Boyer K; Withers S; Levin S; Hubbell J
    Antimicrob Agents Chemother; 1992 May; 36(5):1040-8. PubMed ID: 1510391
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Adverse Event Profile of Pyrimethamine-Based Therapy in Toxoplasmosis: A Systematic Review.
    Ben-Harari RR; Goodwin E; Casoy J
    Drugs R D; 2017 Dec; 17(4):523-544. PubMed ID: 28879584
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.